Acid-induced acute lung injury in mice is associated with p44/42 and c-jun n-terminal kinase activation and requires the function of tumor necrosis factor α receptor i

Shock

Volumn 38, Issue 4, 2012, Pages 381-386

  Maniatis, Nikolaos A ^a,b   Sfika, Aggeliki ^a   Nikitopoulou, Ioanna ^a   Vassiliou, Alice G ^a   Magkou, Christina ^a   Armaganidis, Apostolos ^b   Roussos, Charalambos ^a,b   Kollias, George ^c   Orfanos, Stylianos E ^a,b   Kotanidou, Anastasia ^a,b  

^a EVANGELISMOS HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING   (Greece)

Author keywords

Acid aspiration; acute respiratory distress syndrome; c Jun N terminal kinase; etanercept; mitogen activated kinases; p55

Indexed keywords

CASPASE 3; ETANERCEPT; HYDROCHLORIC ACID; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN; PROTEIN C JUN; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; HISTOPATHOLOGY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG COMPLIANCE; LUNG LAVAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMONIA; SCORING SYSTEM; SIGNAL TRANSDUCTION; WILD TYPE;

ACUTE LUNG INJURY; ANIMALS; APOPTOSIS; BRONCHOALVEOLAR LAVAGE; CASPASE 3; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; FEMALE; GASTRIC ACID; HYDROCHLORIC ACID; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PNEUMONIA, ASPIRATION; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RNA, MESSENGER;

EID: 84866601356     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3182690ea2     Document Type: Article

References (38)

1. Matthay MA, Zemans RL: The acute respiratory distress syndrome: patho-genesis and treatment. Annu Rev Pathol 6:147-163, 2011.
2. Park WY, Goodman RB, Steinberg KP, Ruzinski JT, Radella F 2nd, Park DR, Pugin J, Skerrett SJ, Hudson LD, Martin TR: Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 164(10 Pt 1):1896-1903, 2001.
3. Kollias G, Douni E, Kassiotis G, Kontoyiannis D: On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Immunol Rev 169:175-194, 1999.
4. Teuffel O, Ethier MC, Beyene J, Sung L: Association between tumor necrosis factor-alpha promoter-308 A/G polymorphism and susceptibility to sepsis and sepsis mortality: a systematic review and meta-analysis. Crit Care Med 38(1): 276-282, 2010.
5. Morris PE, Zeno B, Bernard AC, Huang X, Das S, Edeki T, Simonson SG, Bernard GR: A placebo-controlled, double-blind, dose-escalation study to assess the safety, tolerability and pharmacokinetics/pharmacodynamics of single and multiple intravenous infusions of AZD9773 in patients with severe sepsis and septic shock. Crit Care 16(1):R31, 2012.
6. Nomura T, Abe Y, Yoshioka Y, Nakagawa S, Tsunoda S, Tsutsumi Y: Creation of TNFR1-selective antagonist and its therapeutic effects. Yakugaku Zasshi 130(1):63-68, 2010.
7. Rice TW, Wheeler AP, Morris PE, Paz HL, Russell JA, Edens TR, Bernard GR: Safety and efficacy of affinity-purified, anti-tumor necrosis factor-alpha, ovine Fab for injection (CytoFab) in severe sepsis. Crit Care Med 34(9): 2271-2281, 2006.
8. Cho HY, Kleeberger SR: Genetic mechanisms of susceptibility to oxidative lung injury in mice. Free Radic Biol Med 42(4):433-445, 2007.
9. Wilson MR, Choudhury S, Takata M: Pulmonary inflammation induced by high-stretch ventilation is mediated by tumor necrosis factor signaling in mice. Am J Physiol Lung Cell Mol Physiol 288(4):L599-L607, 2005.
10. Wolthuis EK, Vlaar AP, Choi G, Roelofs JJ, Haitsma JJ, van der Poll T, Juffermans NP, Zweers MM, Schultz MJ: Recombinant human soluble tumor necrosis factor-alpha receptor fusion protein partly attenuates ventilator-induced lung injury. Shock 31(3):262-266, 2009.
11. Song Y, Ao L, Raeburn CD, Calkins CM, Abraham E, Harken AH, Meng X: A low level of TNF-alpha mediates hemorrhage-induced acute lung injury via p55 TNF receptor. Am J Physiol Lung Cell Mol Physiol 281(3):L677-L684, 2001.
12. Togbe D, Schnyder-Candrian S, Schnyder B, Doz E, Noulin N, Janot L, Secher T, Gasse P, Lima C, Coelho FR, et al.: Toll-like receptor and tumour necrosis factor dependent endotoxin-induced acute lung injury. Int J Exp Pathol 88(6): 387-391, 2007.
13. Davidson BA, Knight PR, Helinski JD, Nader ND, Shanley TP, Johnson KJ: The role of tumor necrosis factor-alpha in the pathogenesis of aspiration pneumonitis in rats. Anesthesiology 91(2):486-499, 1999.
14. Goldman G, Welbourn R, Kobzik L, Valeri CR, Shepro D, Hechtman HB: Tumor necrosis factor-alpha mediates acid aspirationYinduced systemic organ injury. Ann Surg 212(4):513-520, 1990.
15. van Westerloo DJ, Knapp S, van't Veer C, Buurman WA, de Vos AF, Florquin S, van der Poll: Aspiration pneumonitis primes the host for an exaggerated inflammatory response during pneumonia. Crit Care Med 33(8):1770-1778, 2005.
16. Wajant H, Scheurich P: TNFR1-induced activation of the classical NF-kappaB pathway. FEBS J 278(6):862-876, 2011.
17. Micheau O, Tschopp J: Induction of TNF receptor IYmediated apoptosis via two sequential signaling complexes. Cell 114(2):181-190, 2003.
18. Legler DF, Micheau O, Doucey MA, Tschopp J, Bron C: Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation. Immunity 18(5):655-664, 2003.
19. Johnson GL, Lapadat R: Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298(5600):1911-1912, 2002.
20. Keshet Y, Seger R: The MAP kinase signaling cascades: a system of hundreds of components regulates a diverse array of physiological functions. Methods Mol Biol 661:3-38, 2010.
21. Manali ED, Moschos C, Triantafillidou C, Kotanidou A, Psallidas I, Karabela SP, Roussos C, Papiris S, Armaganidis A, Stathopoulos GT, et al.: Static and dynamic mechanics of the murine lung after intratracheal bleomycin. BMC Pulm Med 11: 33, 2011.
22. Kotanidou A, Loutrari H, Papadomichelakis E, Glynos C, Magkou C, Armaganidis A, Papapetropoulos A, Roussos C, Orfanos SE: Inhaled activated protein C attenuates lung injury induced by aerosolized endotoxin in mice. Vascul Pharmacol 45(2):134-140, 2006.
23. Kuwano K, Hara N: Signal transduction pathways of apoptosis and inflammation induced by the tumor necrosis factor receptor family. Am J Respir Cell Mol Biol 22(2):147-149, 2000.
24. Liu SF, Malik AB: NF-kappa B activation as a pathological mechanism of septic shock and inflammation. Am J Physiol Lung Cell Mol Physiol 290(4): L622-L645, 2006.
25. Mehta D, Malik AB: Signaling mechanisms regulating endothelial permeability. Physiol Rev 86(1):279-367, 2006.
26. Yang G, Hamacher J, Gorshkov B, White R, Sridhar S, Verin A, Chakraborty T, Lucas R: The dual role of TNF in pulmonary edema. J Cardiovasc Dis Res 1(1):29-36, 2010.
27. Abraham E, Anzueto A, Gutierrez G, Tessler S, San Pedro G, Wunderink R, Dal Nogare A, Nasraway S, Berman S, Cooney R, et al.: Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. Lancet 351(9107): 929-933, 1998.
28. Abraham E, Glauser MP, Butler T, Garbino J, Gelmont D, Laterre PF, Kudsk K, Bruining HA, Otto C, Tobin E, et al.: p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group. JAMA 277(19): 1531-1538, 1997.
29. Abraham E, Laterre PF, Garbino J, Pingleton S, Butler T, Dugernier T, Margolis B, Kudsk K, Zimmerli W, Anderson P, et al.: Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients. Crit Care Med 29(3):503-510, 2001.
30. Abraham E, Wunderink R, Silverman H, Perl TM, Nasraway S, Levy H, Bone R, Wenzel RP, Balk R, Allred R, et al.: Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. JAMA 273(12):934-941, 1995.
31. Brouwer MC, McIntyre P, de Gans J, Prasad K, van de Beek D: Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev (9):CD004405, 2010.
32. Heizmann P, Lode H, Heizmann WR: Is monotherapy with beta-lactam antibiotics still up to date? New aspects for treatment of severe infections [in German]. Dtsch Med Wochenschr 137(6):267-270, 2012.
33. Scallon B, Cai A, Solowski N, Rosenberg A, Song XY, Shealy D, Wagner C: Binding and functional comparisons of two types of tumor necrosis factor antagonists. J Pharmacol Exp Ther 301(2):418-426, 2002.
34. Victoratos P, Kollias G: Induction of autoantibody-mediated spontaneous arthritis critically depends on follicular dendritic cells. Immunity 30(1):130-142, 2009.
35. Galani V, Tatsaki E, Bai M, Kitsoulis P, Lekka M, Nakos G, Kanavaros P: The role of apoptosis in the pathophysiology of acute respiratory distress syndrome (ARDS): an up-to-date cell-specific review. Pathol Res Pract 206(3): 145-150, 2010.
36. Di A, Kawamura T, Gao XP, Tang H, Berdyshev E, Vogel SM, Zhao YY, Sharma T, Bachmaier K, Xu J, et al.: A novel function of sphingosine kinase 1 suppression of JNK activity in preventing inflammation and injury. J Biol Chem 285(21):15848-15857, 2010.
37. Zhang X, Bedard EL, Potter R, Zhong R, Alam J, Choi AM, Lee PJ: Mitogen-activated protein kinases regulate HO-1 gene transcription after ischemia-reperfusion lung injury. Am J Physiol Lung Cell Mol Physiol 283(4):L815-L829, 2002.
38. Chaudhury H, Zakkar M, Boyle J, Cuhlmann S, van der Heiden K, Luong le A, Davis J, Platt A, Mason JC, Krams R, et al.: c-Jun N-terminal kinase primes endothelial cells at atheroprone sites for apoptosis. Arterioscler Thromb Vasc Biol 30(3):546-553, 2010.